Associations of maternal BMI and insulin resistance with the maternal metabolome and newborn outcomes

Aims/hypothesisMaternal obesity increases the risk for large-for-gestational-age birth and excess newborn adiposity, which are associated with adverse long-term metabolic outcomes in offspring, probably due to effects mediated through the intrauterine environment. We aimed to characterise the maternal metabolic milieu associated with maternal BMI and its relationship to newborn birthweight and adiposity.MethodsFasting and 1 h serum samples were collected from 400 European-ancestry mothers in the Hyperglycaemia and Adverse Pregnancy Outcome Study who underwent an OGTT at ∼28 weeks gestation and whose offspring had anthropometric measurements at birth. Metabolomics assays were performed using biochemical analyses of conventional clinical metabolites, targeted MS-based measurement of amino acids and acylcarnitines and non-targeted GC/MS.ResultsPer-metabolite analyses demonstrated broad associations with maternal BMI at fasting and 1 h for lipids, amino acids and their metabolites together with carbohydrates and organic acids. Similar metabolite classes were associated with insulin resistance with unique associations including branched-chain amino acids. Pathway analyses indicated overlapping and unique associations with maternal BMI and insulin resistance. Network analyses demonstrated collective associations of maternal metabolite subnetworks with maternal BMI and newborn size and adiposity, including communities of acylcarnitines, lipids and related metabolites, and carbohydrates and organic acids. Random forest analyses demonstrated contribution of lipids and lipid-related metabolites to the association of maternal BMI with newborn outcomes.Conclusions/interpretationHigher maternal BMI and insulin resistance are associated with broad-based changes in maternal metabolites, with lipids and lipid-related metabolites accounting, in part, for the association of maternal BMI with newborn size at birth.

[1]  António S. Barros,et al.  Following healthy pregnancy by NMR metabolomics of plasma and correlation to urine. , 2015, Journal of proteome research.

[2]  David M. Evans,et al.  Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight. , 2016, JAMA.

[3]  Ming-Huei Chen,et al.  Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes , 2016, PloS one.

[4]  William L. Lowe,et al.  Metabolic Networks and Metabolites Underlie Associations Between Maternal Glucose During Pregnancy and Newborn Size at Birth , 2016, Diabetes.

[5]  Timothy M. D. Ebbels,et al.  Genome metabolome integrated network analysis to uncover connections between genetic variants and complex traits: an application to obesity , 2014, Journal of The Royal Society Interface.

[6]  Dorota M. Nowak,et al.  A Combined Metabolomic and Proteomic Analysis of Gestational Diabetes Mellitus , 2015, International journal of molecular sciences.

[7]  H. McIntyre,et al.  Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index , 2010, BJOG : an international journal of obstetrics and gynaecology.

[8]  H. Ortega,et al.  Maternal Lipid Metabolism and Placental Lipid Transfer , 2006, Hormone Research in Paediatrics.

[9]  Y. Pawitan,et al.  Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: A population‐based Swedish cohort study , 2004, American journal of medical genetics. Part A.

[10]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[11]  Tobias Müller,et al.  Bioinformatics Applications Note Systems Biology Bionet: an R-package for the Functional Analysis of Biological Networks , 2022 .

[12]  R. Desert,et al.  Impact of maternal obesity on the metabolic profiles of pregnant women and their offspring at birth , 2015, Metabolomics.

[13]  Alan,et al.  The Hyperglycemia and Adverse Pregnancy Outcome Study Associations of GDM and obesity with pregnancy outcomes , 2012 .

[14]  D. Tudehope,et al.  Obesity in pregnancy: data from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study , 2012 .

[15]  L. Poston,et al.  Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. , 2010, Human reproduction update.

[16]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[17]  K. Flegal,et al.  Trends in Obesity Among Adults in the United States, 2005 to 2014. , 2016, JAMA.

[18]  Ping Liu,et al.  Pregnancy-induced metabolic phenotype variations in maternal plasma. , 2014, Journal of proteome research.

[19]  F. Vaz,et al.  Acylcarnitines , 2012, Diabetes.

[20]  Timothy E. Reddy,et al.  The chromosome 3q25 genomic region is associated with measures of adiposity in newborns in a multi-ethnic genome-wide association study. , 2013, Human molecular genetics.

[21]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..

[22]  J. H. Lee,et al.  Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). , 2010, Journal of proteome research.

[23]  S. Amini,et al.  Estimates of Insulin Sensitivity Using Glucose and C-Peptide From the Hyperglycemia and Adverse Pregnancy Outcome Glucose Tolerance Test , 2009, Diabetes Care.

[24]  Tobias Müller,et al.  Identifying functional modules in protein–protein interaction networks: an integrated exact approach , 2008, ISMB.

[25]  Susan Cheng,et al.  Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans , 2012, Circulation.

[26]  T. Harder,et al.  Birth Weight and Long-Term Overweight Risk: Systematic Review and a Meta-Analysis Including 643,902 Persons from 66 Studies and 26 Countries Globally , 2012, PloS one.

[27]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[28]  C. Barbas,et al.  Metabolic fingerprint of Gestational Diabetes Mellitus. , 2014, Journal of proteomics.

[29]  P. Haggarty.  Fatty acid supply to the human fetus. , 2010, Annual review of nutrition.

[30]  Achim Zeileis,et al.  BMC Bioinformatics BioMed Central Methodology article Conditional variable importance for random forests , 2008 .

[31]  S. Stein,et al.  Deconvolution gas chromatography/mass spectrometry of urinary organic acids--potential for pattern recognition and automated identification of metabolic disorders. , 1999, Rapid communications in mass spectrometry : RCM.

[32]  S. Entringer,et al.  Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy , 2015, PloS one.

[33]  Timothy E. Reddy,et al.  Identification of HKDC1 and BACE2 as Genes Influencing Glycemic Traits During Pregnancy Through Genome-Wide Association Studies , 2013, Diabetes.

[34]  W. Lowe,et al.  Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[35]  P. Catalano,et al.  Is It Time to Revisit the Pedersen Hypothesis in the Face of the Obesity Epidemic , 2012 .

[36]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[37]  A. Hofman,et al.  Body mass index, gestational weight gain and fatty acid concentrations during pregnancy: the Generation R Study , 2015, European Journal of Epidemiology.

[38]  Y. Benjamini,et al.  On the Adaptive Control of the False Discovery Rate in Multiple Testing With Independent Statistics , 2000 .

[39]  E. Tai,et al.  Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men , 2010, Diabetologia.

[40]  O. Fiehn,et al.  FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.

[41]  Sigridur Sia Jonsdottir,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[42]  William L. Lowe,et al.  Metabomxtr: an R package for mixture-model analysis of non-targeted metabolomics data , 2014, Bioinform..

[43]  A. Dyer,et al.  Metabolomics Reveals Broad-Scale Metabolic Perturbations in Hyperglycemic Mothers During Pregnancy , 2013, Diabetes Care.

[44]  J. Reichardt,et al.  Statistical mechanics of community detection. , 2006, Physical review. E, Statistical, nonlinear, and soft matter physics.

[45]  G. Saade,et al.  Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. , 2012, American journal of obstetrics and gynecology.

[46]  A. Dyer,et al.  The Hyperglycemia and Adverse Pregnancy Outcome Study , 2012, Diabetes Care.

[47]  A. Xiang,et al.  The Relative Contribution of Prepregnancy Overweight and Obesity, Gestational Weight Gain, and IADPSG-Defined Gestational Diabetes Mellitus to Fetal Overgrowth , 2012, Diabetes Care.

[48]  Peter Nowotny,et al.  Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. , 2005, Diabetes.

[49]  J. Huynh,et al.  A systematic review of metabolite profiling in gestational diabetes mellitus , 2014, Diabetologia.